Követés
RIEKE ALTEN
RIEKE ALTEN
schlosspark-klinik, charite universitätsmedizin berlin
E-mail megerősítve itt: snafu.de
Cím
Hivatkozott rá
Hivatkozott rá
Év
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
JS Smolen, A Beaulieu, A Rubbert-Roth, C Ramos-Remus, J Rovensky, ...
The Lancet 371 (9617), 987-997, 2008
17882008
Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial
J Braun, J Brandt, J Listing, A Zink, R Alten, W Golder, E Gromnica-Lhle, ...
The Lancet 359 (9313), 1187-1193, 2002
17142002
Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig
JM Kremer, R Westhovens, M Leon, E Di Giorgio, R Alten, S Steinfeld, ...
New England Journal of Medicine 349 (20), 1907-1915, 2003
14222003
Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial
C Gabay, P Emery, R Van Vollenhoven, A Dikranian, R Alten, K Pavelka, ...
The Lancet 381 (9877), 1541-1550, 2013
8362013
Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological …
C Ritchlin, P Rahman, A Kavanaugh, IB McInnes, L Puig, S Li, Y Wang, ...
Annals of the rheumatic diseases 73 (6), 990-999, 2014
7342014
International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis
J Braun, T Pham, J Sieper, J Davis, SJ Van der Linden, M Dougados, ...
Annals of the rheumatic diseases 62 (9), 817-824, 2003
6292003
Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study
T Sokka, S Toloza, M Cutolo, H Kautiainen, H Makinen, F Gogus, V Skakic, ...
Arthritis research & therapy 11, 1-12, 2009
5732009
Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose‐finding, double‐blind, placebo‐controlled clinical trial evaluating CTLA‐4Ig and LEA29Y eighty‐five …
LW Moreland, R Alten, F Van Den Bosch, T Appelboom, M Leon, P Emery, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2002
4952002
Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised …
F Buttgereit, G Doering, A Schaeffler, S Witte, S Sierakowski, ...
The Lancet 371 (9608), 205-214, 2008
4562008
Physical inactivity in patients with rheumatoid arthritis: data from twenty‐one countries in a cross‐sectional, international study
T Sokka, A Häkkinen, H Kautiainen, JF Maillefert, S Toloza, ...
Arthritis Care & Research: Official Journal of the American College of …, 2008
4442008
Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their …
N Schlesinger, RE Alten, T Bardin, HR Schumacher, M Bloch, A Gimona, ...
Annals of the rheumatic diseases 71 (11), 1839-1848, 2012
4132012
Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study
T Sokka, H Kautiainen, T Pincus, SMM Verstappen, A Aggarwal, R Alten, ...
Arthritis research & therapy 12, 1-10, 2010
3812010
Long‐term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three‐month, randomized, placebo‐controlled …
J Braun, J Brandt, J Listing, A Zink, R Alten, G Burmester, W Golder, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2003
3412003
The human anti-IL-1β monoclonal antibody ACZ885 is effective in joint inflammation models in mice and in a proof-of-concept study in patients with rheumatoid arthritis
R Alten, H Gram, LA Joosten, WB Berg, J Sieper, S Wassenberg, ...
Arthritis research & therapy 10, 1-9, 2008
2662008
Filgotinib (GLPG0634/GS-6034), an oral JAK1 selective inhibitor, is effective in combination with methotrexate (MTX) in patients with active rheumatoid arthritis and …
R Westhovens, PC Taylor, R Alten, D Pavlova, F Enríquez-Sosa, M Mazur, ...
Annals of the rheumatic diseases 76 (6), 998-1008, 2017
2652017
Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naive patients …
J Detert, H Bastian, J Listing, A Weiß, S Wassenberg, A Liebhaber, ...
Annals of the rheumatic diseases 72 (6), 844-850, 2013
2582013
Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled …
J Haschka, M Englbrecht, AJ Hueber, B Manger, A Kleyer, M Reiser, ...
Annals of the rheumatic diseases 75 (1), 45-51, 2016
2552016
Persistent clinical response to the anti-TNF-α antibody infliximab in patients with ankylosing spondylitis over 3 years
J Braun, X Baraliakos, J Brandt, J Listing, A Zink, R Alten, G Burmester, ...
Rheumatology 44 (5), 670-676, 2005
2442005
Efficacy and safety of epratuzumab in moderately to severely active systemic lupus erythematosus: results from two phase III randomized, double‐blind, placebo‐controlled trials
MEB Clowse, DJ Wallace, RA Furie, MA Petri, MC Pike, P Leszczyński, ...
Arthritis & rheumatology 69 (2), 362-375, 2017
2362017
Subcutaneous abatacept versus intravenous abatacept: a phase IIIb noninferiority study in patients with an inadequate response to methotrexate
MC Genovese, A Covarrubias, G Leon, E Mysler, M Keiserman, R Valente, ...
Arthritis & Rheumatism 63 (10), 2854-2864, 2011
2362011
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20